Webcast on Demand
On demand webcast: View the webcast from the Boehringer Ingelheim press conference at the ESC 2009 in Barcelona on 30 August.
Value through Innovation17 January 2013
Stroke Prevention in Atrial Fibrillation (SPAF) News and Information
This section includes information and resources about Stroke Prevention in Atrial Fibrillation (SPAF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Stroke Prevention in Atrial Fibrillation (SPAF) Press Releases
| 04.04.2011 |
Breakthrough therapy dabigatran provides consistent benefit across all atrial fibrillation types and stroke risk groups - For NON-US Healthcare Media Only |
|---|---|
| 24.03.2011 |
Dabigatran etexilate is cost-effective for stroke prevention in atrial fibrillation, particularly in real-world clinical practice - For NON-US and Canadian Healthcare Media Only |
| 22.03.2011 |
Survey of people with atrial fibrillation and their doctors uncovers need for more education about the link between AF and stroke |
| 22.03.2011 |
Actress Jane Seymour takes up the fight against common heart rhythm disorder, atrial fibrillation and its link to stroke - For non-UK and non-US media only |
| 21.01.2011 |
PRAZAXA® (dabigatran etexilate) approved in Japan for stroke prevention in atrial fibrillation - For Media outside the U.S. and Canada |
SPAF Related News Room
SPAF Related Documents
Videos
-
-
Prof. Gregory Lip
- Watch the video(QT)
-
-
-
-
-
-
-
-
-
-
-
